このアプリのYoutube動画がある場合はURLを送信してください。詳細 »
APPLICATION INFO - iPhoneアプリの詳細情報
Hereditary cancer risk assessment and referral guidance for clinicians.
Cancer Genetics provides clinicians with streamlined risk assessment and referral guidance for hereditary cancer in an easily accessible and user-friendly format
Cancer Genetics has been developed by the Clinical Genetics department at Guy’s and St Thomas’ NHS Foundation Trust, London, UK in collaboration with the technology company UBQO.
There is increasing public and patient awareness of the contribution of genetic risk to the development of cancer. It is therefore important that primary and secondary care clinicians have easy access to information about hereditary cancer conditions and evidence-based tools that will give them the confidence to refer patients to Clinical Genetics services.
Cancer Genetics enables clinicians to decide which patients should be referred for genetic assessment of their cancer risk and which patients can be reassured and managed in primary or secondary care. It also provides clinicians with a framework of questions that can be used in their clinical approach when managing patients who are concerned about an inherited predisposition to cancer. Cancer Genetics thereby helps to ensure that patients have quicker access to cancer surveillance, genetic counselling, genetic testing, pharmaco-prevention and surgical options to reduce their risk of cancer.
It is often difficult for busy clinicians to access up to date guidance or search for the relevant peer-reviewed literature pertaining to a specific patient. Cancer Genetics provides readily accessible evidence-based cancer risk assessment tools, a succinct reference guide about specific hereditary cancer conditions and links to further information and useful websites. For patients within Guy’s Regional Genetics Service’s catchment area, Cancer Genetics also contains a time-saving email referral option which allows clinicians to refer patients to our service from the palm of their hand.
Cancer Genetics provides streamlined risk assessment and referral guidance for clinicians managing patients concerned about their risk of hereditary cancer. Risk assessment reports are generated based on anonymous information entered by the clinician and can then be saved, e-mailed or printed.
Simple, reliable and time-saving.
Cancer Genetics has MHRA certification as a Class 1 medical device.
Cancer Genetics provides clinicians with streamlined risk assessment and referral guidance for hereditary cancer in an easily accessible and user-friendly format
Cancer Genetics has been developed by the Clinical Genetics department at Guy’s and St Thomas’ NHS Foundation Trust, London, UK in collaboration with the technology company UBQO.
There is increasing public and patient awareness of the contribution of genetic risk to the development of cancer. It is therefore important that primary and secondary care clinicians have easy access to information about hereditary cancer conditions and evidence-based tools that will give them the confidence to refer patients to Clinical Genetics services.
Cancer Genetics enables clinicians to decide which patients should be referred for genetic assessment of their cancer risk and which patients can be reassured and managed in primary or secondary care. It also provides clinicians with a framework of questions that can be used in their clinical approach when managing patients who are concerned about an inherited predisposition to cancer. Cancer Genetics thereby helps to ensure that patients have quicker access to cancer surveillance, genetic counselling, genetic testing, pharmaco-prevention and surgical options to reduce their risk of cancer.
It is often difficult for busy clinicians to access up to date guidance or search for the relevant peer-reviewed literature pertaining to a specific patient. Cancer Genetics provides readily accessible evidence-based cancer risk assessment tools, a succinct reference guide about specific hereditary cancer conditions and links to further information and useful websites. For patients within Guy’s Regional Genetics Service’s catchment area, Cancer Genetics also contains a time-saving email referral option which allows clinicians to refer patients to our service from the palm of their hand.
Cancer Genetics provides streamlined risk assessment and referral guidance for clinicians managing patients concerned about their risk of hereditary cancer. Risk assessment reports are generated based on anonymous information entered by the clinician and can then be saved, e-mailed or printed.
Simple, reliable and time-saving.
Cancer Genetics has MHRA certification as a Class 1 medical device.
このアプリはiPhone、iPadの両方に対応しています。
カテゴリー
メディカル
メディカル
リリース
2016/2/1
2016/2/1
更新
2016/2/5
2016/2/5
バージョン
1.1
1.1
言語
サイズ
2.7 MB
2.7 MB
条件
このバージョンの新機能
Home icon removed from the guidelines
Home icon removed from the guidelines
スクリーンショット - iPhone | iPad
スクリーンショット - iPhone | iPad
UBQO Limited の他のアプリ » もっと見る
» 目的別iPhoneアプリ検索
- 辞書 » 日本語対応の辞書 » 英和辞典
- 学習 » 英単語 » 英会話 » クイズで楽しく
- スケジュール » 管理 » Googleカレンダー
CatchApp新着アプリレビュー
様々な楽しみ方で運転士として成長していく鉄道運転士育成RPG「プラチナ・トレイン(プラトレ) 日本縦断てつどうの旅」
2016-05-17 00:00
日本語にはない英語発音のリスニングを楽しく学べる「発音どっち?英語リスニング 」
2014-12-20 12:00
指先の瞬発力が試されるカジュアルゲーム「早撃ちパニック」をリリース!
2014-12-08 15:21
新着アプリ動画